In 2020, the DNBSEQ-T7 Gene Sequencer of Wuhan MGI Technology Co., Ltd. (hereinafter referred to as “MGI”) was approved (Registration No.: G.X.Z.Z. 20,203,220,061).

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

Illumina said recently that it has received regulatory clearance for its MiSeqDx system from the China National Drug Administration, enabling it to sell the system in China for diagnostic testing. The clearance of the MiSeqDx in China is a

In 2012, genetic testing company 23andMe announced the opening of its Application Programming Interface (API), which wasintended to empower developers to build a wide range of new applications and tools for the 23andMe community.Six years la

Roche said recently that the US Food and Drug Administration has approved its Cobas EGFR Mutation Test v2 as a companion diagnostic test with AstraZenecas cancer drug Iressa (gefitinib) for first-line treatment of patients with non-small ce

Bruker said recently it has signed a definitive agreement to acquire a majority interest in infectious disease molecular diagnostics firm Hain Lifescience.According to Bruker, Nehren, Germany-based Hain will add capabilities in tuberculosis

Bio-Rad Laboratories reported after the close of the market recentlythat its second quarter revenues increased 14 percent year over year, driven by growth in both its Life Science and Clinical Diagnostics businesses. For the three months end

Abbott recently said that its Diagnostics business revenues grew 47 percent year over year in the second quarter, driven by sales in its rapid diagnostics business, which reflect results for Alere acquired in October 2017. On an organic bas

Xiamen Spacegen, a provider of oncology molecular diagnostics products and services in China, said recentlythat it hadreceived CE marking for six testing kits. These kits include a human thyroid carcinoma RET gene fusions detection kit, whic

Recently, Agilent Technologies announced that it has completed the acquisition of ULTRA Scientifics business assets, a supplier of chemical standards and certified reference materials. Agilent identifies chemical standards as a key enabling

Illumina said after the close of the market recently that it intends to offer approximately $650 million of convertible senior notes due 2023. Illumina also intends to grant the initial purchasers a 30-day optionto purchase up to an addition

Finnish consumer genetic testing firm Negen has turned to BC Platforms for analysis of raw genomic data for clinical reporting purposes, the companies announced recently. Under terms of the new partnership, BC Platforms will run data collect